Filters

Human immunodeficiency virus type 2 subtype A Protein Rev (rev)

Human immunodeficiency virus type 2 subtype A Protein Rev (rev) size: 100ug 1376

Price 1376
Size 100ug
Long nameRecombinant Human immunodeficiency virus type 2 subtype A Protein Rev (rev)
Alternative names Protein Rev, Regulator of expression of viral proteins, Protein Rev
Gene namerev
Other gene namesrev
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, Protein Rev (rev) is a recombinant protein expressed in Baculovirus
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetimmunodeficiency virus 2 subtype A Protein Rev (rev)
Short nameimmunodeficiency virus type 2 subtype A Protein Rev (rev)
Species Humans, Human
Alternative name sapiens immunodeficiency virus classification 2 subtype A Protein Rev (rev), H

Similar products

Subscribe to our Newsletter